Blocknomi
Key Takeaways AstraZeneca’s breast cancer treatment camizestrant received a 6-3 rejection vote from FDA’s ODAC panel The company’s prostate cancer therapy Truqap earned a 7-1 favorable recommendation from a separate…
Related articles
-
SHIB Price Gains as Token Burn Rate Rises 24.51%
CryptoNewsZ Published 25.04.2026 11:46
-
Prediction markets are the new secret weapon for Coinbase and Robinhood growth
CoinDesk Published 21.04.2026 19:49
-
Solana price forms bullish double bottom, eyes upside to over $110 on breakout
Crypto.News Published 22.04.2026 12:25
-
Polymarket Launches pUSD and CLOB V2 in Major Exchange Upgrade Scheduled for April 28
Blocknomi Published 27.04.2026 01:24
-
Wisconsin sues Kalshi, Coinbase, Polymarket, calls prediction markets illegal bets
Crypto.News Published 24.04.2026 10:13
-
Tax-free bitcoin is back: How UK investors can avoid paying duty on crypto investments once more
CoinDesk Published 22.04.2026 14:11
-
Crypto scam launderer gets 70 months as DOJ cracks down
Crypto.News Published 26.04.2026 08:08
-
While Popular Cryptos ADA and LTC Slump, Crypto Enthusiasts Move to Spartans.com Following the Million-Dollar RAF Partnership
Blocknomi Published 23.04.2026 20:00